Quantcast

Coherus BioSciences Management to Present at Jefferies 2019 Global Healthcare Conference

By GlobeNewswire,  May 22, 2019, 09:30:00 AM EDT


REDWOOD CITY, Calif., May 22, 2019 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today announced that senior management will present at the Jefferies 2019 Global Healthcare Conference in New York City on Tuesday, June 5, 2019 at 10:00 a.m. ET.

The audio portion of the presentation will be available on the investors page of the Coherus BioSciences website at http://investors.coherus.com.

About Coherus BioSciences, Inc.

Coherus BioSciences is a leading biosimilar company that develops and commercializes high-quality therapeutics for major regulated markets. Biosimilars are intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases, with the potential to reduce costs and expand patient access. Composed of a team of proven industry veterans with world-class expertise in process science, analytical characterization, protein production, sales and marketing and clinical-regulatory development, Coherus BioSciences is positioned as a leader in the global biosimilar marketplace. Coherus BioSciences commercializes UDENYCA® (pegfilgrastim-cbqv) in the U.S. and has received regulatory approval for UDENYCA® in the European Union. Coherus BioSciences is advancing two late-stage clinical products towards commercialization, CHS-1420 (adalimumab biosimilar) and CHS-0214 (etanercept biosimilar), and developing a robust pipeline of future products in ophthalmology (including CHS-3351, a ranibizumab biosimilar, and CHS-2020, an aflibercept biosimilar), as well as CHS-131, a small molecule for nonalcoholic steatohepatitis (NASH) and multiple sclerosis. For additional information, please visit www.coherus.com.

About Coherus BioSciences, Inc.

David S. Arrington

VP, Investor Relations & Corporate Affairs

Coherus BioSciences, Inc.

darrington@coherus.com

+1 (650) 395-0196            

Source: Coherus BioSciences, Inc.

This article appears in: News Headlines

Referenced Stocks: CHRS










Today's Market Activity

NASDAQ 7796.66
-40.47  ▼  0.52%
DJIA 26089.61
-17.16  ▼  0.07%
S&P 500 2886.98
-4.66  ▼  0.16%
Data as of Jun 14, 2019